Prof. Hani Gabra, MD

Dr. Gabra is Professor of Medical Oncology and Deputy Head of the Division of Cancer (Clinical). He is Head of the Molecular Therapeutics Unit and Director of the Ovarian Cancer Action Research Centre at Imperial College, London, UK. Within Imperial College Healthcare NHS Trust he is Head of Medical Oncology, Chair of the Cancer Research Committee and is Honorary Consultant Medical Oncologist. He is also Associate Director and Lead of the Cancer Division of the NIHR Clinical Research Network for North West London. His clinical / translational interests relate to the understanding of platinum resistance in ovarian cancer, and he has developed several molecular targets whose inhibition can reverse platinum resistance from laboratory to clinic; such targets include AKT, MTOR, HDAC4, STAT1 and the Folate Receptors. Hani's research is principally funded by Ovarian Cancer Action, the national ovarian cancer charity. He is also funded by CRUK and EU FP7 as well as translational / clinical trials funding from pharmaceutical collaborations.